-
09
Sep, 2026
Parkinson’s Disease: A Silent Neurodegenerative Threat & Natural Neuro‑Suppor...
Parkinson’s disease (PD) is one of the most common progressive neurodegenerative disorders worldwide. According to global burden‑of‑disease research data, patients in China account for 23% of all P...
-
21
Aug, 2026
Understanding Parkinson’s Disease: Symptoms, Self‑Assessment, Clinical Manage...
Parkinson’s Disease (PD), also called shaking palsy, is a chronic progressive neurodegenerative disorder that predominantly affects middle‑aged and elderly populations. Its hallmark clinical manife...
-
17
Aug, 2026
Beyond Neurons: How Cistanche Tubulosa Protects The Brain's Microvasculature ...
When we think about brain health, we tend to think about neurons. But neurons cannot survive without the intricate network of microvessels that delivers oxygen and glucose to every corner of the br...
-
12
Aug, 2026
Cistanche, Take You To Decipher The 'silent Killer' in Your Father's Body - P...
The overlooked illusion of aging: Parkinson's, the silent killer hidden in the father's body Father's aging has never happened overnight. It is hidden in the gradually graying temples, ...
-
12
Aug, 2026
Cistanche Benefits For Anti-Parkinson's Disease: Natural Neuroprotective Supp...
Stiff limbs, slow movement, unsteady gait, persistent constipation, loss of smell, uncontrollable resting tremors, and declining mood and memory—these troubling signals are typical warnings of Park...
-
11
Aug, 2026
Protective Effect And Mechanism Of Glycosides Of Cistanches In An MPTP-Induce...
Abstract Objective: To investigate the neuroprotective effect of glycosides of Cistanches (GCs) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease (PD) mouse model...
-
07
Aug, 2026
The Potential Of Cistanche Tubulosa in The Treatment And Prevention Of Parkin...
Parkinson's disease (PD) is the second-largest neurodegenerative disease in the world, with a prevalence rate of about 1.7% among people aged 65 and above in China. The total number of patients...
-
29
Jul, 2026
Cistanche Benefits For Anti-Parkinson's Disease: Natural Neuroprotective Supp...
Parkinson’s disease progresses due to irreversible loss of dopamine-producing neurons and toxic alpha-synuclein buildup. While clinical medications relieve surface motor symptoms, daily dietary ant...
-
21
Jul, 2026
Cistanche Tubulosa As A Traditional Chinese Medicine,Its Potential in The Tre...
Introduction Parkinson's disease (PD) is the second largest neurodegenerative disease worldwide, characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta ...
-
21
Jul, 2026
Mechanism Research And Clinical Application Progress Of Cistanche Tubulosa in...
Parkinson's disease (PD) is the second largest neurodegenerative disease after Alzheimer's disease, characterized by progressive loss of dopaminergic neurons in the substantia nigra of the ...
-
21
Jul, 2026
Protecting The Aging Brain: How Cistanche Tubulosa Targets The Root Causes Of...
Alzheimer's disease (AD) is the most common cause of dementia, affecting an estimated 55 million people worldwide-a number projected to triple by 2050. It is a disease that strips away memory, ...
-
17
Jul, 2026
Parkinson’s Disease: Early Warning Signs, Home Care Strategies & Science-Back...
Parkinson’s disease spans decades of slow progression, burdening patients with physical discomfort and psychological distress. Three pillars form the foundation of effective anti-Parkinson manageme...
